Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
Director comp.
Acq. announced
Director departure
|
|
RHYTHM PHARMACEUTICALS, INC. (RYTM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 11% stake in RHYTHM PHARMACEUTICALS INC |
| 02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 9.8% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 11.3% stake in Rhythm Pharmaceuticals, Inc. |
| 02/09/2023 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 12.3% stake in Rhythm Pharmaceuticals, Inc. |
| 02/09/2023 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 2.2% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 11.2% stake in RHYTHM PHARMACEUTICALS, INC. |
| 10/07/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10.9% stake in Rhythm Pharmaceuticals, Inc. |
| 04/11/2022 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 10.1% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 7.7% stake in Rhythm Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 9.7% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 5.6% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 6.2% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/10/2022 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 12.4% stake in Rhythm Pharmaceuticals, Inc. |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/24/2020 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 8% stake in Rhythm Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| THIRD ROCK VENTURES LP reports a 0.7% stake in Rhythm Pharmaceuticals, Inc. |
| 10/18/2019 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC reports a 12.7% stake in RHYTHM PHARMACEUTICALS, INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| THIRD ROCK VENTURES LP reports a 9% stake in Rhythm Pharmaceuticals, Inc. |
|
|